Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury

Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury

Midkine (MK) is a small secreted heparin-binding protein highly expressed during embryonic/fetal development which, through interactions with multiple cell surface receptors promotes growth through effects on cell proliferation, migration, and differentiation. MK is upregulated in the adult central...

Full description

Bibliographic Details
Main Authors: Emily Ross-Munro, Faith Kwa, Jenny Kreiner, Madhavi Khore, Suzanne L. Miller, Mary Tolcos, Bobbi Fleiss, David W. Walker
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Neurology
Subjects:
midkine
neurotrophins
hypoxia
neuroinflammation
perinatal brain damage
preterm birth
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.568814/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2020.568814/full

Similar Items